Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06643507

Evaluation of the Modified VISTA Technique Using ALB-PRF vs CTG in the Treatment of Multiple Miller Class III Recessions

Clinical Evaluation of the Modified VISTA Technique (M-VISTA )Using Albumin-platelet Rich Fibrin (Alb-PRF) Versus Connective Tissue Graft (CTG)in the Treatment of Multiple Miler Class III RT2 Recessions A Randomized Clinical Trial

Status
Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
26 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

treatment of miller class III RT2 gingival recession using modified vista technique using connective tissue graft vs albumin PRF

Detailed description

treatment of gingival recession is an important element in the treatment of periodontitis this study covers clinical evaluation of using the modified VISTA technique with using Albumin-PRF VS connective tissue graft in the treatment of miller class III / RT2 for root coverage outcomes

Conditions

Interventions

TypeNameDescription
OTHERConnective tissue graftregenerative properties
BIOLOGICALALB-PRFregenerative properties

Timeline

Start date
2025-04-20
Primary completion
2026-12-20
Completion
2027-01-30
First posted
2024-10-16
Last updated
2026-03-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06643507. Inclusion in this directory is not an endorsement.